Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)

INTRODUCTION: Two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines, tozinameran/BNT162b2 (Comirnaty®, Pfizer-BioNTech) and elasomeran/mRNA-1273 (Spikevax®, Moderna), were approved by the Food and Drug Administration (FDA) and the European Medicines Agency (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Valnet-Rabier, Marie-Blanche, Tebacher, Martine, Gautier, Sophie, Micallef, Joelle, Salvo, Francesco, Pariente, Antoine, Bagheri, Haleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2023
Materias:
Pharmacovigilance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007713/
https://www.ncbi.nlm.nih.gov/pubmed/37012149
http://dx.doi.org/10.1016/j.therap.2023.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007713/
https://www.ncbi.nlm.nih.gov/pubmed/37012149
http://dx.doi.org/10.1016/j.therap.2023.03.005

Ejemplares similares